Survivors of cancer often describe a sense of abandonment after treatment along with heightened uncertainty and limited knowledge of what lies ahead. This study examined the efficacy of a survivorship care plan (SCP) intervention to help physicians to address survivorship issues through communication skills training plus a new consultation focused on the use of an SCP for patients with Hodgkin lymphoma and diffuse large B-cell lymphoma. METHODS: This 4-site cluster randomized trial examined the efficacy of a survivorship planning consultation (SPC) in patients who achieved complete remission after the completion of first-line therapy (for the SPC, physicians received communication skills training and, using an SCP, applied those skills in a survivorship-focused office visit) versus a control arm in which physicians were trained in and subsequently provided a time-controlled, manualized wellness rehabilitation consultation (WRC) focused only on discussion of healthy nutrition and exercise as rehabilitation after chemotherapy. The primary outcomes for patients were changes in knowledge about lymphoma and adherence to physicians' recommendations for vaccinations and cancer screenings. RESULTS: Forty-two physicians and 198 patients participated across the 4 sites. Patients whose physicians were in the SPC arm had greater knowledge about their lymphoma (P = .01) and showed greater adherence to physician recommendations for influenza vaccinations (P = .02) and colonoscopy (P = .02) than patients whose physicians were in the WRC arm. CONCLUSIONS: A dedicated consultation using an SCP and supported by communication skills training may enhance patients' knowledge and adherence to some health promotion recommendations.
INTRODUCTION
Many patients with cancer feel unprepared for the transition from active treatment to survivorship. The Institute of Medicine's report on cancer survivorship, From Cancer Patient to Cancer Survivor: Lost in Transition, describes the unique quality-of-care needs of survivors. 1 Survivors have many questions and unmet needs (eg, timing of follow-up visits, late and long-term effects of treatment, and other recommended tests/screenings), and they are also at risk for recurrence and new cancers. [2] [3] [4] [5] Many patients with Hodgkin lymphoma (HL) and diffuse large B-cell lymphoma (DLBCL) achieve a complete response and go into remission. [6] [7] [8] Complete response rates are close to 90%, and there are relatively low relapse rates. [9] [10] [11] Lymphoma survivors may have many of the aforementioned challenges. [12] [13] [14] [15] One approach for facilitating this transition, endorsed by the American Society of Clinical Oncology and others, includes treatment summaries and survivorship care plans (SCPs). 16, 17 The Institute of Medicine recommends SCPs for all survivors, including a written summary of the Cancer December 1, 2018 treatment received, health promotion recommendations, and a schedule for monitoring possible recurrence and other treatment-related risks. 18 It is believed that an SCP may facilitate the process of initiating and integrating healthy behaviors into daily life. 19, 20 Improving patients' understanding of their illness and self-care may enhance adherence to physicians' recommendations. 21 Although SCPs have been shown to be well received by survivors, [22] [23] [24] most have failed to demonstrate effects on knowledge and behavior. 22 However, exceptions exist. In a study of survivors of breast and colorectal cancer, SCPs resulted in increased cancer knowledge, 25 and another recent study demonstrated that SCPs coupled with nurse counseling led to greater implementation of recommended breast survivorship care. 26 Thus, an SCP is a promising tool to help survivors to manage their needs and ensure that they do not fall through the cracks of the health care system, 1 but the evidence base is limited. An important limitation of past studies is that the SCPs were used with patients, but physicians were not taught how to best use them with patients. Accordingly, the goal of this trial was to examine the efficacy of a survivorship planning consultation (SPC) with patients who had achieved complete remission. SPC physicians received communication skills training and applied those skills in a new survivorship-focused consultation using an SCP. Physicians in the control arm were trained in and subsequently provided a wellness rehabilitation consultation (WRC) that focused on healthy nutrition and exercise discussion. We previously reported on the efficacy of the communication skills training in helping physicians to learn skills for introducing SCPs. 27 This article describes the 2 primary research hypotheses: patients of physicians in the SPC arm would exhibit a greater increase in knowledge about lymphoma and its treatment and would have higher rates of self-reported adherence to physician recommendations in the first year of survivorship.
MATERIALS AND METHODS

Study Design
Participating sites were randomized to either the SPC or WRC arm in a cluster randomized design, which protected against physician contamination of the intervention within any site. We selected 2 larger sites and 2 smaller sites with similar numbers of patients with lymphoma, and randomization was stratified by site size. The study was approved by the sites' institutional review boards. Additional details about the study design have been published elsewhere. 28 
Participants and Recruitment
Physicians
All oncologists in the lymphoma services who saw patients with HL and DLBCL received an introduction letter. Interested oncologists proceeded to have a discussion with an investigator from the research team and provided informed consent. Forty-four physicians were screened and consented (22 in the SPC arm and 22 in the WRC arm; 2 physicians in the WRC arm withdrew and did not attend the training). Physicians did not receive compensation.
Patients
Patients were recruited through their physicians' clinics. Patients were eligible if they had a diagnosis of HL or DLBCL and were treated with curative intent, had testing indicating complete remission, were 18 years old or older, and were fluent in English. Patients were ineligible if they showed evidence of significant cognitive impairment or had a prognosis and/or comorbidities that, in the physician's judgment, made them inappropriate for participation. Patients were recruited at the time they were informed of remission, and they completed the baseline (T1) questionnaires before their first posttreatment consultation. Patients completed questionnaires after that visit (the 1-month [T2] follow-up visit) and after their 3-(T3), 6-(T4), 9-(T5), and 12-month (T6) follow-up visits. They were compensated for their time (T2 visit, $20; T3 visit, $30; T4 visit, $40; T5 visit, $50; T6 visit, $60).
SPC
Physicians in the SPC arm completed 5 hours of inperson communication skills training, which included information about lymphoma survivorship, exemplary videos of recommended communication strategies for a survivorship consultation, survivorship-themed role playing with standardized patients (trained actors), and a discussion about the benefits of and barriers to SCP implementation. 27 Then, patients and physicians participated in a brief (15-minute) new consultation approximately 1 month after the baseline visit, which was focused on transitioning the patients to survivorship. In this visit, physicians reviewed the scans showing the remission status and then reviewed the SCP and facilitated a discussion about survivorship-related concerns and behaviors. The SCP consisted of a summary of the cancer diagnosis and treatments received, treatment-relevant toxicities, the frequency of future visits, the screening schedule, and a review of health promotion behaviors (vaccinations, Cancer December 1, 2018 exercise, nutrition, and smoking cessation). Consultations were audio-recorded for fidelity monitoring.
WRC
Physicians in the WRC arm received 2 hours of in-person training focused only on wellness and lifestyle factors. These physicians had a time-matched consultation with their patients 1 month after the baseline visit in which they reviewed scans showing the remission status and discussed the benefits of healthy nutrition and walking to promote fitness. Consultations were audio-recorded for fidelity monitoring.
Fidelity
Fidelity monitoring was conducted with the Transition to Survivorship Coding Schema (SPC) 27 and with a checklist describing the prescribed behaviors related to healthy nutrition and exercise (WRC). 28 The goal of the fidelity assessment was to ensure that physician consultations were standardized.
In both arms, after the T2 visit, all physicians received an e-mail describing strengths and focusing on topics to discuss with patients about the use of the SCP or a healthy nutrition and exercise handout, respectively. After the physicians' next 2 visits, they received a follow-up phone call if their fidelity score for the prescribed behaviors related to the study condition was less than 80% of recommended behaviors (n = 17 or 41%). After the fourth visit, all physicians received an e-mail thanking them for their participation, asking about any concerns, and providing constructive feedback, if needed. After the fifth, sixth, and seventh visits, physicians got a follow-up phone call if their adherence score was less than 80% of recommended behaviors (n = 6 or 14%).
Assessment and Evaluation Plan
Assessment of physicians SPC physicians participated in pre-and posttraining Standardized Patient Assessments, a reliable assessment with discriminant validity. 29, 30 Blinded coding was completed with the Comskil Coding System and the Specific Coding Schema for Skills, Strategies, and Process Tasks. 27 There was a significant uptake in communication skills from the pretraining period to the posttraining period. 27 
Assessment of patients
Demographics
At the baseline, patients provided the following information: work status, marital status, education, race, and ethnicity.
Lymphoma Knowledge Questionnaire
This 50-item questionnaire examined knowledge about lymphoma; its treatment, long-term and late effects, and prognosis; and health recommendations (content from the National Cancer Institute Web site). 28 It was validated with 320 survivors of lymphoma (6 months to 6 years after treatment), whose average score was 22.8 (standard deviation, 9.1). Items were true or false with a "don't know" option, and the knowledge score was a sum of the total correct answers (range, 0-50), with missing answers counted as incorrect. It was administered at the baseline and at 1, 3, and 12 months and was scored if at least 1 item was answered.
Employment and Health Services QuestionnaireAdherence
The Adherence subscale of the Employment and Health Services Questionnaire was used to assess adherence to recommended vaccinations and screening tests. 28 We assessed 7 preventative and screening behaviors (mammogram, Papanicolaou [Pap] test, colonoscopy or fecal occult blood test (FOBT), flu vaccination, pneumococcal vaccination, skin screening, and annual primary care provider visit). Patients reported adherence at the 3-, 6-, 9-, and 12-month follow-up visits. We assessed the completion of these behaviors and dates for colonoscopy, Pap testing, and mammograms, if reported. We combined colonoscopy and FOBT as a single indicator of colorectal cancer screening.
Statistical Plan
Increases in knowledge were analyzed longitudinally via 3-level hierarchical linear modeling (HLM) with assessment, patient, and site levels. The primary HLM for knowledge included 2 fixed effects: baseline knowledge and treatment arm (eg, SPC or WRC). Random intercepts for both the patient and the site were included to adjust for a correlation introduced by repeated measures. Each patient contributed up to 3 time points. Three additional fixed-effect predictors were considered: 1) the main effect of the assessment time point (3 levels), 2) the time-treatment interaction, and 3) the quadratic time effect. The general form of the models was as follows:
where the knowledge score for the ith person within the jth site at the t time point (Knowledge ijt ) was regressed on random person (α i ) and site (α j ) effects as well as baseline
Cancer December 1, 2018 knowledge (Knowledge ij0 ) and a treatment indicator (Arm j ) plus additional predictors (X ij ) as listed previously. Akaike information criteria were used for model comparisons between the primary model and the inclusion of additional predictors. We used an intent-to-treat approach in comparing the 2 study arms. Models presented unadjusted associations, although similar effects were found in models adjusted for demographic covariates.
Sample size calculations for this study were based on the ability to collect longitudinal patient-level data from at least 224 patients (of 256 enrolled) to detect an intervention effect of 0.61 in standardized mean difference scores (Cohen's d) 31 between the study arms; there was an assumed intraclass correlation of 0.10 among patients nested within physicians at a 2-sided type I error rate of .01 to provide some control of multiple comparisons of the outcomes of knowledge and adherence. 32 Each adherence outcome was assessed both as a logit outcome in generalized HLM and via Cox proportional hazards models to incorporate the differential follow-up time for the adherence measures. In logistic HLM models, adherence for each outcome was treated as a single binary outcome, and patients were considered nonadherent unless they affirmed adherence. The general form for the logistic model was as follows:
where adherence for the ith person within the jth site (Adherence ij ) was regressed on random site effects and an indicator for the SPC arm. In proportional hazards models, no failures were imputed; rather, patients contributed a unique measure of follow-up time as well as an indicator of whether the outcome was successful at the time of the final assessment. Thus, the proportional hazards model incorporated differential attrition. To adjust for site effects, the robust sandwich variance estimator for proportional hazards models was used, as developed by Lee et al. 33 These separate models allowed a more complete analysis of the data, both with and without imputed failures, and they were fitted for each of the 7 behaviors. Patient profiles that did not meet US Preventive Services Task Force general requirements for the screening were excluded; specifically, only women older than 40 years were included for mammograms, only women younger than 65 years were included for Pap tests, and only patients between the ages of 50 and 75 years were included for colonoscopy or FOBT. The statistical package SAS 9.4 was used.
RESULTS
Participant Characteristics
Forty-two physicians were enrolled across the 4 sites (22 in the SPC arm and 20 in the WRC arm; Table 1 ). One hundred ninety-eight patients were enrolled: 117 (59%) at SPC sites and 81 (41%) at WRC sites (Fig. 1) . Patients were largely white and non-Hispanic and were evenly distributed by sex and between earlier and later stages at diagnosis (51% at stages 1 and 2 and 48% at stages 3 and 4). Patients' ages ranged from 18 to 87 years (see Table 2 ). Attrition did not differ between the arms by patient characteristics at any time point, although the SPC participants provided more complete data at the last 3 time points (T4 visit, P = .01; T5 and T6 visits, P < .01). Intermittent missingness also did not differ by patient or disease characteristics, so patients who completed all surveys were comparable to patients who missed at least 1 survey (all P values > .10).
Knowledge
Patients' baseline knowledge scores ranged from 3 to 40 (mean, 22.2; standard deviation, 6.7) with no difference by treatment arm and with an intraclass correlation coefficient of 0.03 for the clinics. Patients in both arms had increases in knowledge over time; at 1 month, the SPC patients had an average increase of 4.1 points, and WRC patients had an average increase of 1.3 points. These increases were sustained through 12 months (Table 3) . After adjustments for baseline knowledge and random participant and site effects, participants in the SPC arm had an average increase in knowledge 2.36 points (F(1, 232) = 6.70; P = .01; 95% confidence interval, 0.54-4.18) higher than the increase for WRC participants. Model fit comparisons determined a model with the baseline knowledge, study arm, and time to be the best fit, although all models under consideration (ie, models with linear and quadratic time effects and the model with an arm-time interaction) showed a significant effect of the treatment arm.
Adherence
Among women older than 40 years, 52% reported undergoing a mammogram, and 39% of women younger than 65 years reported undergoing a Pap test during the follow-up year. Among patients aged 50 to 75 years, 9% reported undergoing colonoscopy or FOBT. For all participants, 50%, 14%, 16%, and 34% reported receiving a flu vaccine, a pneumococcal vaccine, a skin cancer screening from a dermatologist, and a primary care provider annual examination, respectively. Both logistic
HLM and proportional hazards models showed that SPC patients were more than twice as likely to get a flu vaccine as WRC patients (odds ratio, 2.42; 95% confidence interval, 1.16-5.02 [logistic model]). Colorectal cancer screening rates could not be compared via models because no patients aged 50 to 75 years in the WRC group completed colonoscopy or FOBT; however, an exact chi-square test of the overall counts found the observed difference to be statistically significant (P = .016). Notably, proportional hazards models of the adherence outcomes were also used to assess effects of baseline knowledge, but because there were no significant findings, knowledge was not used as a covariate in the final models for adherence (see Table 4 ).
DISCUSSION
SCPs have been conceptualized as helpful to patients by enhancing their knowledge and management of the disease and their awareness of late and long-term side effects through active screening and health monitoring. Documented evidence for these presumed benefits has been minimal. We tested the use of a new consultation for providing SCPs to patients, and we used communication skills training as the means to ensure physicians' comfort and efficiency with this approach. Our results suggest that patients may benefit from survivorship-dedicated consultations in terms of improved knowledge and some increased uptake of recommended screening and vaccination behaviors. Evaluating whether the change in knowledge is clinically significant is challenging. Using a frequently suggested criterion of half a standard deviation, 34 we found that the SPC patients exhibited a clinically significant change in knowledge that WRC patients did not. The relative differences between the SPC and WRC arms were slightly smaller. Revicki et al 35 proposed using the effect size to evaluate clinical significance. With this criterion, the effect size for the difference in knowledge between the arms was 0.33 (a small to medium effect size). Growth in knowledge about one's illness is the necessary first step in improved health literacy to empower enhanced health promotion and self-care. Abbreviations: DLBCL, diffuse large B-cell lymphoma; HL, Hodgkin lymphoma; SPC, survivorship planning consultation; WRC, wellness rehabilitation consultation. The arms differed only by the number of DLBCL cases. Some percentages do not sum to 100 due to rounding.
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The influenza vaccine is one clear recommendation made for the first year of survivorship after the treatment of lymphoma. This was a behavioral gain after the use of an SCP; however, the impact of rituximab on patient immunity leads physicians to generally wait until year 2 to recommend the pneumococcal vaccine. This reality lay outside our follow-up time line, and this is why we did not see improved rates of pneumococcal vaccination. Colonoscopy screening improved, but other behaviors such as mammography and Pap tests did not. Our adherence outcome data were limited by the short follow-up time in this study and the timing and variations in when screening or vaccinations were due.
There are many informational gaps identified in patients after active treatment, [2] [3] [4] and there is great variability in the content of the discussions that patients have with their providers. 5 Our results demonstrate that a targeted new visit may be beneficial. There is compelling evidence in the literature about the value of being sufficiently informed or educated about one's health condition and care because a lack of such understanding can result in noncompliance with physician recommendations and thereby adversely affect patient outcomes.
36-38
The quality of this consultation was likely enhanced by our multilevel intervention approach: we intervened not only at the system level (new consultation) but also at the provider level. The training included how to effectively use the SCP. Other studies without the communication skills training component have typically shown that although patients are satisfied with the SCPs, their use has not resulted in other positive outcomes. 6 Although some educational and communication intervention studies have Cancer December 1, 2018 been found to increase knowledge, 39, 40 research has been mixed about whether they result in improvements in behavior. 41, 42 Importantly, our study found positive effects on both of these key outcomes (knowledge and behavior).
This study had some limitations. First, participants were primarily white and English-speaking. There may have been some differences between the sites that may have affected the outcomes. However, each site was diverse in physician experience and in types of lymphoma, but physicians in each arm were similar except for a marginal difference in the number of patients with DLBCL. Additional studies should focus on more ethnically and socioeconomically diverse populations and community hospitals to determine whether a similar intervention would be effective. Having comorbidities that could limit participation was an eligibility criterion. This could have biased our results; however, this criterion was not mentioned as a reason to not approach patients, so it is unlikely. Physicians also had to be interested and willing to participate, and this could have biased the results, although we had full participation at all sites. Our adherence outcome data were also limited by dropouts and potential underestimation because only 46% of patients in the WRC arm and 55% in the SPC arm completed all follow-up surveys, and we did not have detailed data for these outcomes (eg, total hysterectomy negating the need Cancer December 1, 2018 for a Pap test). However, our use of a time-to-event analysis and the analysis of dichotomous outcomes mitigated some of the dropout issue, and we do not believe that there was differential underestimation of adherence by arm. Therefore, we believe that the group comparison is valid. It should also be recognized that this study included only 4 sites, and this may limit its generalizability. However, we included both larger and smaller volume sites and provided data on patients and physicians to fully describe the study sites. Although physicians between arms were largely comparable, there was a noticeable difference in the percentage of time that the physicians spent in clinical practice. Although adjustments are made for clinician effects in the random intercept models, the effects may not be completely disentangled if this represents a fundamental difference between the participating sites. This was a generally brief intervention, and fidelity to some components of the consultation was somewhat low. A longer intervention might enhance fidelity but might also limit physicians' interest in participating in the program.
What was innovative about this design was the dedicated use of a new consultation focused on cancer survivorship. We believe that this is justified, and we plan to evaluate its cost-effectiveness. Although other types of clinicians may also provide survivorship care, this intervention was targeted at oncologists because they typically meet with patients to discuss the completion of treatment, and we believe that they are ideally positioned for these initial survivorship conversations. These survivorship consultations occurred in the regular outpatient clinic run by each physician. However, follow-up screenings and vaccinations were left to a patient's primary care provider or family practitioner to complete. Consultations were covered by each patient's usual health insurance. Future studies could examine the effects of the training on patients' psychosocial adjustments and quality of life and the utility of making the training available in online modules to facilitate physicians' ability to obtain the training to enhance generalizability.
This novel SPC intervention has the potential to enhance the survivorship experience for patients who have recently received news of being cancer-free and may be unprepared for this transition. SCPs have many elements and warrant dedicated consultations to empower the patients and help them to discuss and understand the variety of survivorship issues that they may encounter. This model could subsequently be modified for use with other cancer survivors. 
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